South Korea
· Delayed Price · Currency is KRW Ildong Pharmaceutical Statistics
Total Valuation
KRX:249420 has a market cap or net worth of KRW 351.11 billion. The enterprise value is 485.27 billion.
| Market Cap | 351.11B |
| Enterprise Value | 485.27B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:249420 has 27.93 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Current Share Class | 27.93M |
| Shares Outstanding | 27.93M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 2.41% |
| Owned by Institutions (%) | 3.76% |
| Float | 16.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.59 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | 17.22 |
| P/OCF Ratio | 11.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.99, with an EV/FCF ratio of 23.80.
| EV / Earnings | -178.71 |
| EV / Sales | 0.81 |
| EV / EBITDA | 11.99 |
| EV / EBIT | 31.90 |
| EV / FCF | 23.80 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 1.19.
| Current Ratio | 0.79 |
| Quick Ratio | 0.41 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 4.86 |
| Debt / FCF | 9.72 |
| Interest Coverage | 0.99 |
Financial Efficiency
Return on equity (ROE) is -5.81% and return on invested capital (ROIC) is 2.56%.
| Return on Equity (ROE) | -5.81% |
| Return on Assets (ROA) | 1.65% |
| Return on Invested Capital (ROIC) | 2.56% |
| Return on Capital Employed (ROCE) | 5.63% |
| Revenue Per Employee | 580.66M |
| Profits Per Employee | -2.63M |
| Employee Count | 1,033 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 4.15 |
Taxes
| Income Tax | -2.06B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.76% in the last 52 weeks. The beta is 1.09, so KRX:249420's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -3.76% |
| 50-Day Moving Average | 12,036.00 |
| 200-Day Moving Average | 12,308.80 |
| Relative Strength Index (RSI) | 52.43 |
| Average Volume (20 Days) | 60,901 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:249420 had revenue of KRW 599.82 billion and -2.72 billion in losses. Loss per share was -97.21.
| Revenue | 599.82B |
| Gross Profit | 225.49B |
| Operating Income | 15.49B |
| Pretax Income | -12.06B |
| Net Income | -2.72B |
| EBITDA | 40.76B |
| EBIT | 15.49B |
| Loss Per Share | -97.21 |
Balance Sheet
The company has 69.13 billion in cash and 198.28 billion in debt, giving a net cash position of -129.15 billion or -4,623.74 per share.
| Cash & Cash Equivalents | 69.13B |
| Total Debt | 198.28B |
| Net Cash | -129.15B |
| Net Cash Per Share | -4,623.74 |
| Equity (Book Value) | 166.46B |
| Book Value Per Share | 5,779.90 |
| Working Capital | -62.27B |
Cash Flow
In the last 12 months, operating cash flow was 30.87 billion and capital expenditures -10.47 billion, giving a free cash flow of 20.39 billion.
| Operating Cash Flow | 30.87B |
| Capital Expenditures | -10.47B |
| Free Cash Flow | 20.39B |
| FCF Per Share | 730.09 |
Margins
Gross margin is 37.59%, with operating and profit margins of 2.58% and -0.45%.
| Gross Margin | 37.59% |
| Operating Margin | 2.58% |
| Pretax Margin | -2.01% |
| Profit Margin | -0.45% |
| EBITDA Margin | 6.80% |
| EBIT Margin | 2.58% |
| FCF Margin | 3.40% |
Dividends & Yields
KRX:249420 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.25% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.77% |
| FCF Yield | 5.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Mar 5, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
KRX:249420 has an Altman Z-Score of 1.72 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.72 |
| Piotroski F-Score | 6 |